Cutaneous manifestations in relation to immunologic parameters in a cohort of primary myelodysplastic syndrome patients

Journal of the European Academy of Dermatology and Venereology

Volumn 22, Issue 5, 2008, Pages 543-548

  Dalamaga, M ^a,b,d   Karmaniolas, K ^b   Matekovits, A ^b   Migdalis, I ^b   Papadavid, E ^c  

^a NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

^b G Gennimatas Hospital   (Greece)

^c UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^d NONE   (Greece)

Author keywords

Cutaneous manifestations; Myelodysplastic syndromes; Parameters to immunologic disorders

Indexed keywords

ANTINUCLEAR ANTIBODY; IMMUNOGLOBULIN G; PARAPROTEIN; RHEUMATOID FACTOR;

ACUTE FEBRILE NEUTROPHILIC DERMATOSIS; ACUTE LEUKEMIA; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; AUTOIMMUNE DISEASE; CLINICAL FEATURE; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; ECCHYMOSIS; FEMALE; FOLLOW UP; HIGH RISK POPULATION; HISTOPATHOLOGY; HUMAN; HYPERGAMMAGLOBULINEMIA; IMMUNOLOGICAL PARAMETERS; MAJOR CLINICAL STUDY; MALE; MALIGNANT TRANSFORMATION; MOUTH ULCER; MYELODYSPLASTIC SYNDROME; PHOTOSENSITIVITY DISORDER; POLYCHONDRITIS; PRIORITY JOURNAL; PROGNOSIS; PRURIGO; PURPURA; RASH; SEX DIFFERENCE; SKIN BIOPSY; SKIN EXAMINATION; SKIN MANIFESTATION; SUBCUTANEOUS NODULE; SYSTEMIC LUPUS ERYTHEMATOSUS; VASCULITIS; WEGENER GRANULOMATOSIS;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY; COHORT STUDIES; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERGAMMAGLOBULINEMIA; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK FACTORS; SKIN; SKIN DISEASES;

EID: 42149189967     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2007.02520.x     Document Type: Article

References (29)

1. Block M, Jacobsen LO, Bethard WF. Preleukemic acute human leukemia. JAMA 1953; 152: 1018-1028.
2. Rheingold JJ, Kaufman R, Adelson E, Lear A. Smoldering acute leukemia. N Engl J Med 1963; 268: 812-815.
3. List AF, Doll DF. The myelodysplastic syndromes. In: Foerster GR, Lukens LJ, Paraskevas F, Greer JP, Rodgers GM, eds. Wintrobe's Clinical Hematology, 10th edn, Vol. 2. Williams & Wilkins, Baltimore, 1999: 2320-2333.
4. Aul C, Germing U, Gattermann N, Minning H. Increasing incidence of myelodysplastic syndromes: Real or fictitious? Leuk Res 1998; 22: 93-100.
5. San Miguel JF, Sanz GF, Vallespi T, del Canizo MC, Sanz MA. Myelodysplastic syndromes. Crit Rev Oncol Hematol 1996; 23: 57.
6. Ahmad YH, Kiehl R, Papac RJ. Myelodysplasia. The clinical spectrum of 51 patients. Cancer 1995; 76: 869-874.
7. Aul C, Gattermann N, Schneider W. Age-related incidence and other epidemiologic aspects of myelodysplastic syndromes. Br J Haematol 1992; 82: 358.
8. Watson KM, Mufti G, Salisbury JR, du Vivier AW, Creamer D. Spectrum of clinical presentation, treatment and prognosis in a series of eight patients with leukaemia cutis. Clin Exp Dermatol 2006; 31: 218-221.
9. Pont V, Miquel FJ, Grau TC et al. Skin involvement in chronic myelomonocytic leukaemia as a predictor of transformation into acute myeloid leukaemia. J Eur Acad Dermatol Venereol 2001; 15: 260-262.
10. Desch JK, Smoller BR. The spectrum of cutaneous disease in leukemias. J Cutan Pathol 1993; 20: 407.
11. Pomeroy C, Oken MM, Rydell RE, Filice GA. Infection in the myelodysplastic syndrome. Am J Med 1991; 90: 338-344.
12. Vignon-Pennamen MD, Juillard C, Rybojad M et al. Chronic recurrent lymphocytic sweet syndrome as a predictive marker of myelodysplasia: A report of 9 cases. Arch Dermatol 2006; 142: 1170-1176.
13. Morand JJ, Lightburn E, Richard MA, Hesse-Bonerandi S, Carsuzaa F, GrobJJ. Skin manifestations associated with myelodysplastic syndromes. Rev Med Interne 2001; 22: 845-853.
14. Vazquez Garcia J, Almagro Sanchez M, Fonseca Capdevila E. Multiple neutrophilic dermatoses in myelodysplastic syndromes. Clin Exp Dermatol 2001; 26: 398-401.
15. Avivi I, Rosenbaum H, Levy Y, Rowe J. Myelodysplastic syndromes and associated skin lesions: A review of the literature. Leuk Res 1999; 23: 323-330.
16. Bennett M, Catovsky D, Daniel MT et al. Proposals for the classification of MDS. Br J Haematol 1982; 51: 189.
17. Greenberg P, Cox C, LeBeau MM et al. International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood 1997; 89: 2079-2088.
18. McAdam LP, O'Hanlan MA, Bluestone R, Pearson CM. Relapsing polychondritis: Prospective study of 23 patients and a review of the literature. Medicine (Baltimore) 1976; 55: 193-215.
19. Diebold L, Rauh G, Jager K, Lohrs U. Bone marrow pathology in relapsing polychondritis: High frequency of myelodysplastic syndromes. Br J Haematol 1995; 89: 820-830.
20. Sarkany RP, Ross G, Willis F. Acquired eythropoietic protoporphyria as a result of myelodysplasia causing loss of chromosome 18. Br J Dermatol 2006; 155: 464-466.
21. Aractingi S, Bachmeyer C, Miclea JM et al. Unusual specific cutaneous lesions in myelodysplastic syndromes. J Am Acad Dermatol 1995; 33: 187-191.
22. Papadavid E, Panayiotides J, Katoulis A et al. Stasis dermatitis like leukaemic infiltration in a patient with myelodysplastic syndrome. Clin Exp Dermatol, in press.
23. Longacre TA, Smoller BR. Leukaemia cutis, analysis of 50 proven cases with an emphasis on occurrence in myelodysplastic syndromes. Am J Clin Pathol 1993; 100: 276-284.
24. Hamblin TJ. Immunological abnormalities in myelodysplastic syndromes. Semin Hematol 1996; 33: 150-162.
25. Enright H, Jacob HS, Vercellotti G, Howe R, Belzer M, Miller W. Paraneoplastic autoimmune phenomena in patients with myelodysplastic syndromes: Response to immunosuppressive therapy. Br J Haematol 1995; 91: 403-408.
26. Billstrom R, Johansson H, Johansson B, Mitelman F. Immune-mediated complications in patients with myelodysplastic syndromes-clinical and cytogenetic features. Eur J Haematol 1995; 55: 42-48.
27. Giannouli S, Voulgarelis M, Zintzaras E, Tzioufas AG, Moutsopoulos HM. Autoimmune phenomena myelodysplastic syndromes: A 4-year prospective study. Rheumatology 2004; 43: 626-632.
28. Voulgarelis M, Giannouli S, Ritis K, Tzioufas AG. Myelodysplasia-associated autoimmunity; clinical and pathophysiologic concepts. Eur J Clin Invest 2004; 34: 690-700.
29. Okamoto T, Okada M, Mori A et al. Correlation between immunological abnormalities and prognosis in myelodysplastic syndrome patients. Int J Hematol 1997; 66: 345-351.